2026 ASCO-SEP Edition Has Launched
American Society of Clinical Oncology (ASCO), shared a post on LinkedIn: “We’re excited to announce the 2026 ASCO-SEP® edition has launched! Whether you’re studying for the boards or looking to stay…
Read the full articleYou might also wanna read
ASCO Day 3: Pancreatic cancer advance earns standing ovation; Akeso and Summit face disappointment
ASCO Day 3: A huge advance for pancreatic cancer, a let down for Akeso and Summit, and a new approach to immunotherapy.
ASCO 2026: New hope in AL amyloidosis, with Dr Hans Lee
ASCO 2026: New hope in AL amyloidosis, with Dr Hans Lee Jonah.Comstock Wed, 08/07/2026 - 19:48

US Cancer Trends, Projections for 2026
The latest report from the American Cancer Society, published in CA: A Cancer Journal for Clinicians, reveals a complex picture—declining mo

Quarterly Highlights from the Health & Clinical Research and Life Sciences Communities (April to June 2026)
We’re halfway through 2026! It’s time to reflect on some popular posts shared across the Health & Clinical Research and Life Sciences Commun
Tempus AI presents initial multimodal foundation model results for oncology insight generation at ASCO 2026
Model built on 2.5M patient records and 500K sequences hit 0.802 C-index and HR 4.536 in EGFR lung cancer, hinting at faster trial design an

Open Access Week 2025: “Who Owns Our Knowledge?”
There is a revolution happening in how medical knowledge moves through the world. At its heart is a question both rehearsed and urgent: who

Comments
Sign in to join the conversation.
No comments yet. Be the first.